Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elmar Jaeckel

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
JHEP Reports : Innovation in Hepatology|August 12, 2021
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosisAlena Laschtowitz, Kalliopi Zachou, Vasiliki Lygoura, et al.
Gut|November 27, 2019
Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cellsZhen Dai, Guangqi Song, Asha Balakrishnan, et al.
The Journal of Clinical Investigation|December 14, 2011
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantationFelix Bohne, Marc Martínez-Llordella, Juan-José Lozano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2025
Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transferWeijie Du, Fatih Noyan, Oliver McCallion, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 10, 2019
Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune HepatitisSimon Pape, Tom J G Gevers, Michail Belias, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 15, 2024
Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: An intention-to-treat analysisOwen Jones, Marco P A W Claasen, Tommy Ivanics, et al.
Clinical and Experimental Immunology|January 12, 2022
Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trialAndrzej Chruscinski, Vanessa Rojas-Luengas, Sajad Moshkelgosha, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
From model to man: Understanding Tregs' dual role in MASLDJanine Dywicki, Laura Elisa Buitrago-Molina, Anna K Baumann, et al.
Molecular Metabolism|January 24, 2025
Novel translational mouse models of metabolic dysfunction-associated steatotic liver disease comparable to human MASLD with severe obesityKatharina L Hupa-Breier, Heiko Schenk, Alejandro Campos-Murguia, et al.
Journal of Hepatology|April 10, 2022
Corrigendum to 'Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model' [J Hepatol (2021) 1420-1433]Taihua Yang, Marion Poenisch, Rajendra Khanal, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
JHEP Reports : Innovation in Hepatology|August 12, 2021
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosisAlena Laschtowitz, Kalliopi Zachou, Vasiliki Lygoura, et al.
Gut|November 27, 2019
Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cellsZhen Dai, Guangqi Song, Asha Balakrishnan, et al.
The Journal of Clinical Investigation|December 14, 2011
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantationFelix Bohne, Marc Martínez-Llordella, Juan-José Lozano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2025
Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transferWeijie Du, Fatih Noyan, Oliver McCallion, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 10, 2019
Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune HepatitisSimon Pape, Tom J G Gevers, Michail Belias, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 15, 2024
Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: An intention-to-treat analysisOwen Jones, Marco P A W Claasen, Tommy Ivanics, et al.
Clinical and Experimental Immunology|January 12, 2022
Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trialAndrzej Chruscinski, Vanessa Rojas-Luengas, Sajad Moshkelgosha, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
From model to man: Understanding Tregs' dual role in MASLDJanine Dywicki, Laura Elisa Buitrago-Molina, Anna K Baumann, et al.
Molecular Metabolism|January 24, 2025
Novel translational mouse models of metabolic dysfunction-associated steatotic liver disease comparable to human MASLD with severe obesityKatharina L Hupa-Breier, Heiko Schenk, Alejandro Campos-Murguia, et al.
Journal of Hepatology|April 10, 2022
Corrigendum to 'Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model' [J Hepatol (2021) 1420-1433]Taihua Yang, Marion Poenisch, Rajendra Khanal, et al.
Pageof 15